Identification and characterization of 2 HIV-1 Gag immunodominant epitopes restricted by Asian HLA allele HLA-B*4801

Human Immunology

Volumn 70, Issue 3, 2009, Pages 170-174

  Murakoshi, Hayato ^a   Kitano, Mitsutaka ^a   Akahoshi, Tomohiro ^a   Kawashima, Yuka ^a   Dohki, Sachi ^a   Oka, Shinichi ^a,b   Takiguchi, Masafumi ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

^b NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

Author keywords

Cytotoxic T lymphocytes; Epitopes; HIV 1; HLA B*4801

Indexed keywords

EPITOPE; GAG PROTEIN; HLA ANTIGEN CLASS 1; HLA B4801 ANTIGEN; NEF PROTEIN; POL PROTEIN; UNCLASSIFIED DRUG;

ALLELE; ARTICLE; ASIAN; BLOOD SAMPLING; CD8+ T LYMPHOCYTE; CYTOTOXIC T LYMPHOCYTE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; IMMUNOPATHOGENESIS; PRIORITY JOURNAL;

ASIAN CONTINENTAL ANCESTRY GROUP; CD8-POSITIVE T-LYMPHOCYTES; CELL LINE, TRANSFORMED; EPITOPE MAPPING; GAG GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; HIV INFECTIONS; HIV-1; HLA-B ANTIGENS; HUMANS; IMMUNODOMINANT EPITOPES; INTERFERON-GAMMA; LYMPHOCYTE ACTIVATION; NEF GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; PEPTIDES; POL GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS;

EID: 61349107130     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humimm.2008.12.011     Document Type: Article

References (30)

1. Barker E., Mackewicz C.E., Reyes-Teran G., Sato A., Stranford S.A., Fujimura S.H., et al. Virological and immunological features of long-term human immunodeficiency virus-infected individuals who have remained asymptomatic compared with those who have progressed to acquired immunodeficiency syndrome. Blood 92 (1998) 3105-3114
2. Klein M.R., van Baalen C.A., Holwerda A.M., Kerkhof Garde S.R., Bende R.J., Keet I.P., et al. Kinetics of Gag-specific cytotoxic T lymphocyte responses during the clinical course of HIV-1 infection: A longitudinal analysis of rapid progressors and long-term asymptomatics. J Exp Med 181 (1995) 1365-1372
3. McMichael A.J., and Rowland-Jones S.L. Cellular immune responses to HIV. Nature 410 (2001) 980-987
4. Schmitz J.E., Kuroda M.J., Santra S., Sasseville V.G., Simon M.A., Lifton M.A., et al. Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes. Science 283 (1999) 857-860
5. Borrow P., Lewicki H., Wei X., Horwitz M.S., Peffer N., Meyers H., et al. Antiviral pressure exerted by HIV-1-specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus. Nat Med 3 (1997) 205-211
6. Goulder P.J., Philips R.E., Colbert R.A., McAdam S., Ogg G., Nowak M.A., et al. Late escape from an immunodominant cytotoxic T lymphocyte response associated with progression to AIDS. Nat Med 3 (1997) 212-217
7. Collins K.L., Chen B.K., Kalams S.A., Walker B.D., and Blatimore D. HIV-1 Nef protein protects infected primary cells against killing by cytotoxic T lymphocytes. Nature 391 (1998) 397-401
8. Xu X.N., Laffert B., Screaton G.R., Kraft M., Wolf D., Kolanus W., et al. Induction of Fas ligand expression by HIV involves the interaction of Nef with the T cell receptor zeta chain. J Exp Med 189 (1999) 1489-1496
9. Mueller Y.M., De Rosa S.C., Hutton J.A., Witek J., Roederer M., Altman J.D., et al. Increased CD95/Fas-induced apoptosis of HIV-specific CD8(+) T cells. Immunity 15 (2001) 871-882
10. Champagne P., Ogg G.S., King A.S., Knabenhans C., Ellefsen K., Nobile M., et al. Skewed maturation of memory HIV-specific CD8 T lymphocytes. Nature 410 (2001) 106-111
11. Ikeda-Moore Y., Tomiyama H., Miwa K., Oka S., Iwamoto A., Kaneko Y., et al. Identification and characterization of multiple HLA-A24-restricted HIV-1 CTL epitopes: Strong epitopes are derived from V regions of HIV-1. J Immunol 159 (1997) 6242-6252
12. Kawashima Y., Satoh M., Oka S., and Takiguchi M. Identification and characterization of HIV-1 epitopes presented by HLA-A*2603: Comparison between HIV-1 epitopes presented by A*2601 and A*2603. Hum Immunol 66 (2005) 1155-1166
13. Tomiyama H., Miwa K., Shiga H., Ikeda-Moore Y., Oka S., Iwamoto A., et al. Evidence of presentation of multiple HIV-1 cytotoxic T lymphocyte epitopes by HLA-B*3501 molecules that are associated with the accelerated progression of AIDS. J Immunol 158 (1997) 5026-5034
14. Dong T., Boyd D., Rosenberg W., Alp N., Takiguchi M., McMichael A.J., et al. An HLA-B35-restricted epitope modified at an anchor residue results in an antagonist peptide. Eur J Immunol 26 (1996) 335-339
15. Goulder P.J., Reid S.W., Price D.A., O'Callaghan C.A., McMichael A.J., Phillips R.E., et al. Combined structural and immunological refinement of HIV-1 HLA-B8-restricted cytotoxic T lymphocyte epitopes. Eur J Immunol 27 (1997) 1515-1521
16. Addo M.M., Altfeld M., Rosenberg E.S., Eldridge R.L., Philips M.N., Habeeb K., et al. The HIV-1 regulatory proteins Tat and Rev are frequently targeted by cytotoxic T lymphocytes derived from HIV-1-infected individuals. Proc Natl Acad Sci U S A 98 (2001) 1781-1786
17. Goulder P.J., Addo M.M., Altfeld M.A., Rosenberg E.S., Tang Y., Govender U., et al. Rapid definition of five novel HLA-A*3002-restricted human immunodeficiency virus-specific cytotoxic T-lymphocyte epitopes by ELISPOT and intracellular cytokine staining assays. J Virol 75 (2001) 1339-1347
18. Draenert R., Altfeld M., Brander C., Basgoz N., Corcoran C., Wurcel A.G., et al. Comparison of overlapping peptide sets for detection of antiviral CD8 and CD4 T cell responses. J Immunol Methods 275 (2003) 19-29
19. Kitano M., Kobayashi N., Kawashima Y., Akahoshi T., Nokihara K., Oka S., et al. Identification and characterization of HLA-B*5401-restricted HIV-1-Nef and Pol-specific CTL epitopes. Microbes Infect 10 (2008) 764-772
20. Imanishi T., Akaza T., Kimura A., Tokunaga K., and Gojobori T. Allele and haplotype frequencies for HLA and complement loci in various ethnic groups. In: Tsuji K., Aizawa M., and Sasazuki T. (Eds). HLA 1991: Proceedings of the Eleventh International Histocompatibility Workshop and Conference (1992), Oxford University Press, Oxford 1065-1220
21. Cao K., Hollenbach J., Shi X., Shi W., Chopek M., and Fernandez-Vina M.A. Analysis of the frequencies of HLA-A, -B, and C alleles and haplotypes in the five major ethnic groups of the United States reveals high levels of diversity in these loci and contrasting distribution patterns in these populations. Hum Immunol 62 (2001) 1009-1030
22. Cao K., Hollenbach J.A., Shi X.J., Shi W.X., Chopek M., and Fernandez-Vina M.A. HLA-A, -B and -Cw allele frequencies in a Caucasian population from the USA. Hum Immunol 65 (2004) 1196-1198
23. Shaw C.K., Chen L.L., Lee A., and Lee T.D. Distribution of HLA gene and haplotype frequencies in Taiwan: A comparative study among Min-nan, Hakka, Aborigines and Mainland Chinese. Tissue Antigens 53 (1999) 51-64
24. Itoh Y., Mizuki N., Shimada T., Azuma F., Itakura M., Kashiwase K., et al. High-throughput DNA typing of HLA-A, -B, -C, and -DRB1 loci by a PCR-SSOP-Luminex method in the Japanese population. Immunogenetics 57 (2005) 717-729
25. Akari H., Arold S., Fukumori T., Okazaki T., Strebel K., and Adachi A. Nef-induced major histocompatibility complex class I down-regulation is functionally dissociated from its virion incorporation, enhancement of viral infectivity, and CD4 down-regulation. J Virol 74 (2000) 2907-2912
26. + T-cell cytolytic activity and cytokine production. J Virol 76 (2002) 7535-7543
27. Martinez-Naves E., Barber L.D., Madrigal J.A., Vullo C.M., Clayberger C., Lyu S.C., et al. Interactions of HLA-B*4801 with peptide and CD8. Tissue Antigens 50 (1997) 258-264
28. + T-cell epitopes. J Virol 81 (2007) 3667-3672
29. Falk K., Rötzschke O., Takiguchi M., Gnau V., Stevanović S., Jung G., et al. Peptide motifs of HLA-B38 and B39 molecules. Immunogenetics 41 (1995) 162-164
30. + T-cell responses to different HIV proteins have discordant associations with viral load. Nat Med 13 (2007) 46-53